MetLife Investment Management LLC Cuts Position in Axon Enterprise, Inc. (NASDAQ:AXON)

MetLife Investment Management LLC lessened its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.5% in the third quarter, Holdings Channel reports. The firm owned 21,938 shares of the biotechnology company’s stock after selling 328 shares during the period. MetLife Investment Management LLC’s holdings in Axon Enterprise were worth $8,766,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of AXON. Westfield Capital Management Co. LP increased its position in shares of Axon Enterprise by 12.2% in the third quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock worth $469,661,000 after acquiring an additional 127,769 shares in the last quarter. Champlain Investment Partners LLC increased its holdings in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares in the last quarter. 1832 Asset Management L.P. raised its position in Axon Enterprise by 44.0% in the second quarter. 1832 Asset Management L.P. now owns 375,700 shares of the biotechnology company’s stock valued at $110,546,000 after purchasing an additional 114,800 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Axon Enterprise by 13.9% during the second quarter. Allspring Global Investments Holdings LLC now owns 368,732 shares of the biotechnology company’s stock worth $108,496,000 after purchasing an additional 45,049 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA acquired a new stake in shares of Axon Enterprise in the third quarter valued at about $120,553,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Stock Up 0.4 %

NASDAQ:AXON opened at $634.96 on Friday. The firm has a market capitalization of $48.42 billion, a PE ratio of 164.07, a price-to-earnings-growth ratio of 13.97 and a beta of 0.94. Axon Enterprise, Inc. has a 52 week low of $224.28 and a 52 week high of $641.20. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. The stock has a 50 day moving average of $478.27 and a 200-day moving average of $374.80.

Insider Transactions at Axon Enterprise

In other news, CEO Patrick W. Smith sold 75,000 shares of the stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $356.53, for a total value of $26,739,750.00. Following the completion of the transaction, the chief executive officer now directly owns 2,970,366 shares in the company, valued at $1,059,024,589.98. This trade represents a 2.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, President Joshua Isner sold 20,000 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total value of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at approximately $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 210,256 shares of company stock worth $87,783,120. Insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on AXON. The Goldman Sachs Group boosted their price target on Axon Enterprise from $385.00 to $441.00 and gave the stock a “buy” rating in a research report on Wednesday, October 23rd. JMP Securities upped their target price on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Craig Hallum lifted their price target on shares of Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Robert W. Baird upped their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Finally, Barclays lifted their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, Axon Enterprise currently has an average rating of “Moderate Buy” and a consensus price target of $427.83.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.